In recent years, Tau has represented a focus of interest since it is primarily involved in many neurodegenerative diseases (among them, Alzheimer's disease), commonly defined as tauopathies (Gerson et al., 2016; Kovacs, 2017). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.